In the present study, we investigated the prognostic value of the mutational status of the KRAS, NRAS, PIK3CA and BRAF genes detected in tumor biopsies and plasma samples from 51 synchronous metastatic colorectal cancer (SMCC) patients. The gene discussed is KRAS; the disease is neoplasm.